DARE·23666P200·US·equity·Healthcare - Biotechnology-13D/G
DARE (DARE BIOSCIENCE INC) is held by 17 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($323,703), US BANCORP \DE\ ($166,293), UBS Group AG ($78,921). Net institutional sentiment: Mixed.
See how DARE's score breaks down across 4 SEC sources
Showing 1-20 of 22
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer